New FDA draft guidance examines devices with quantitative imaging functions

The FDA has released a new draft guidance focused on the completion of premarket submissions for medical devices with quantitative imaging functions. Submissions for such devices should include additional information, according to the FDA, due to their key role in patient care and susceptibility to “systematic errors and random variation.”